| ERK: a key player in the pathophysiology of cardiac hypertrophy S Gallo, A Vitacolonna, A Bonzano, P Comoglio, T Crepaldi International journal of molecular sciences 20 (9), 2164, 2019 | 210 | 2019 |
| Cellular and molecular mechanisms of HGF/Met in the cardiovascular system S Gallo, V Sala, S Gatti, T Crepaldi Clinical science 129 (12), 1173-1193, 2015 | 152 | 2015 |
| Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy S Gallo, S Gatti, V Sala, R Albano, P Costelli, E Casanova, PM Comoglio, ... Cell death & disease 5 (4), e1185-e1185, 2014 | 75 | 2014 |
| HGF and MET: from brain development to neurological disorders C Desole, S Gallo, A Vitacolonna, F Montarolo, A Bertolotto, D Vivien, ... Frontiers in Cell and Developmental Biology 9, 683609, 2021 | 59 | 2021 |
| Signaling to cardiac hypertrophy: insights from human and mouse RASopathies V Sala, S Gallo, C Leo, S Gatti, BD Gelb, T Crepaldi Molecular medicine 18, 938-947, 2012 | 53 | 2012 |
| MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine V Sala, S Bergerone, S Gatti, S Gallo, A Ponzetto, C Ponzetto, T Crepaldi Cellular and molecular life sciences 71, 1439-1452, 2014 | 48 | 2014 |
| HGF/Met axis in heart function and cardioprotection S Gallo, V Sala, S Gatti, T Crepaldi Biomedicines 2 (4), 247-262, 2014 | 46 | 2014 |
| Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing A Galluzzo, S Gallo, B Pardini, G Birolo, P Fariselli, P Boretto, ... ESC Heart Failure 8 (4), 2907-2919, 2021 | 30 | 2021 |
| Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro S Gallo, M Spilinga, R Albano, G Ferrauto, E Di Gregorio, E Casanova, ... British Journal of Pharmacology 177 (13), 3107-3122, 2020 | 22 | 2020 |
| Gene expression profiling of HGF/Met activation in neonatal mouse heart S Gatti, C Leo, S Gallo, V Sala, E Bucci, M Natale, D Cantarella, E Medico, ... Transgenic research 22, 579-593, 2013 | 17 | 2013 |
| Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1, 2 signalling with Pimasertib V Sala, S Gallo, S Gatti, E Medico, E Vigna, D Cantarella, L Fontani, ... Journal of molecular and cellular cardiology 93, 84-97, 2016 | 14 | 2016 |
| NMDA receptor and its emerging role in cancer S Gallo, A Vitacolonna, T Crepaldi International Journal of Molecular Sciences 24 (3), 2540, 2023 | 11 | 2023 |
| A new transgenic mouse model of heart failure and cardiac cachexia raised by sustained activation of met tyrosine kinase in the heart V Sala, S Gatti, S Gallo, E Medico, D Cantarella, J Cimino, A Ponzetto, ... BioMed Research International 2016, 2016 | 11 | 2016 |
| A mouse model for spatial and temporal expression of HGF in the heart I Riess, V Sala, C Leo, M Demaria, S Gatti, S Gallo, A Fitou, O Boero, ... Transgenic research 20, 1203-1216, 2011 | 11 | 2011 |
| The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1, 2-Timp1-Stat3 S Gallo, M Spilinga, E Casanova, A Bonzano, C Boccaccio, PM Comoglio, ... International Journal of Molecular Sciences 21 (15), 5258, 2020 | 6 | 2020 |
| The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor DM Altintas, S Gallo, C Basilico, M Cerqua, A Bocedi, A Vitacolonna, ... International Journal of Molecular Sciences 23 (20), 12427, 2022 | 4 | 2022 |
| MET oncogene controls invasive growth by coupling with NMDA receptor S Gallo, A Vitacolonna, P Comoglio, T Crepaldi Cancers 14 (18), 4408, 2022 | 4 | 2022 |
| Engineering, characterization, and biological evaluation of an antibody targeting the HGF receptor C Desole, S Gallo, A Vitacolonna, E Vigna, C Basilico, F Montarolo, ... Frontiers in Immunology 12, 775151, 2021 | 4 | 2021 |
| HGF/Met axis has anti-apoptotic and anti-autophagic function in hypoxic cardiac injury S Gallo, S Gatti, V Sala, PM Comoglio, T Crepaldi Receptors & Clinical Investigation 1, 2014 | 4 | 2014 |
| Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody C Modica, S Gallo, C Chiriaco, M Spilinga, PM Comoglio, T Crepaldi, ... Cancers 12 (3), 741, 2020 | 3 | 2020 |
